tiprankstipranks
Daehan Nupharm Co., Ltd. (KR:054670)
:054670
South Korea Market

Daehan Nupharm Co., Ltd. (054670) Price & Analysis

Followers

054670 Stock Chart & Stats

₩5670.00
₩30.00(0.53%)
--

054670 FAQ

What was Daehan Nupharm Co., Ltd.’s price range in the past 12 months?
Daehan Nupharm Co., Ltd. lowest stock price was ₩5030.00 and its highest was ₩7900.00 in the past 12 months.
    What is Daehan Nupharm Co., Ltd.’s market cap?
    Daehan Nupharm Co., Ltd.’s market cap is ₩79.16B.
      When is Daehan Nupharm Co., Ltd.’s upcoming earnings report date?
      Daehan Nupharm Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 70 days.
        How were Daehan Nupharm Co., Ltd.’s earnings last quarter?
        Daehan Nupharm Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩802.519 earnings per share for the quarter.
          Is Daehan Nupharm Co., Ltd. overvalued?
          According to Wall Street analysts Daehan Nupharm Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Daehan Nupharm Co., Ltd. pay dividends?
            Daehan Nupharm Co., Ltd. does not currently pay dividends.
            What is Daehan Nupharm Co., Ltd.’s EPS estimate?
            Daehan Nupharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Daehan Nupharm Co., Ltd. have?
            Daehan Nupharm Co., Ltd. has 14,354,920 shares outstanding.
              What happened to Daehan Nupharm Co., Ltd.’s price movement after its last earnings report?
              Daehan Nupharm Co., Ltd. reported an EPS of ₩802.519 in its last earnings report. Following the earnings report the stock price went up 1.375%.
                Which hedge fund is a major shareholder of Daehan Nupharm Co., Ltd.?
                Currently, no hedge funds are holding shares in KR:054670
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Daehan Nupharm Co., Ltd. (054670) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Sam-A Pharm. Co., Ltd.
                  Osang Healthcare Co. Ltd.
                  iNtRON Biotechnology, Inc.
                  Optipharm Co., Ltd.
                  Enzychem Lifesciences Corp.
                  Popular Stocks